1 March 2019 in The American Journal of Human Genetics
Gene-panel and whole-exome analyses are now standard methodologies for mutation detection in Mendelian disease. However, the diagnostic yield achieved is at best 50%, leaving the genetic basis for disease unsolved in many individuals. New approaches are thus needed to narrow the diagnostic gap. Whole-genome sequencing is one potential strategy, but it currently has variant-interpretation challenges, particularly for non-coding changes. In this study we focus on transcriptome analysis, specifically total RNA sequencing (RNA-seq), by using monogenetic neuromuscular disorders as proof of principle. We examined a cohort of 25 exome and/or panel "negative" cases and provided genetic resolution in 36% (9/25). Causative mutations were identified in coding and non-coding exons, as well as in intronic regions, and the mutational pathomechanisms included transcriptional repression, exon skipping, and intron inclusion. We address a key barrier of transcriptome-based diagnostics: the need for source material with disease-representative expression patterns. We establish that blood-based RNA-seq is not adequate for neuromuscular diagnostics, whereas myotubes generated by transdifferentiation from an individual's fibroblasts accurately reflect the muscle transcriptome and faithfully reveal disease-causing mutations. Our work confirms that RNA-seq can greatly improve diagnostic yield in genetically unresolved cases of Mendelian disease, defines strengths and challenges of the technology, and demonstrates the suitability of cell models for RNA-based diagnostics. Our data set the stage for development of RNA-seq as a powerful clinical diagnostic tool that can be applied to the large population of individuals with undiagnosed, rare diseases and provide a framework for establishing minimally invasive strategies for doing so.
1 June 2020 in Journal of the American Medical Directors Association
20 May 2026 in npj Digital Medicine
Recent years have seen a surge in the development of Artificial Intelligence (AI) technologies to enhance intraoperative decision-making and improve patient safety. Yet, real-world evidence on their implementation remains limited. This study evaluated the impact of AI deployment in the operating room across key implementation domains-usability, cost, and carbon footprint-using cloud and edge-based infrastructures. Twenty-three end-users (surgeons, residents, fellows, operating room nurses) from a multi-site teaching hospital in Canada participated in system usability testing, assessed with validated scales and open-ended feedback. Cost and carbon footprint were assessed based on operational metrics. Results showed greater deployment task completion with Cloud but increased physical strain, carbon emissions, and operational costs compared to Edge after 396 h of use. Despite similar usability ratings, participants suggested improvements to the Cloud setup and both systems' interface. Findings provide evidence-based recommendations toward the implementation of sustainable, user-centered AI systems in surgical practice.